Skip to content
Disclosery

13F-HR filed by SUPERSTRING CAPITAL MANAGEMENT LP

SUPERSTRING CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 36 holding rows worth $84,456,465.

Accession
0001931118-25-000006
Filer
CIK 1931118
Filed
2025-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 36 entries on the cover page, a total value of $84,456,465 stated on the cover page (in dollars after the unit check, H1), rows summing to $84,456,465 with VALUE read as dollars as filed, 13F file number 028-23866. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
COGENT BIOSCIENCES INC19240Q201COM962,951$6,913,988dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS68,982$6,524,318dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM40,608$5,104,020dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock1,286,681$4,799,320dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM130,422$4,742,144dollars as filed
ZAI LAB LTD ADR98887Q104ADR134,895$4,717,278dollars as filed
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock44,107$4,680,635dollars as filed
SOLENO THERAPEUTICS INC834203309COM50,000$4,189,000dollars as filedput
BRIDGEBIO PHARMA INC10806X102COM96,766$4,178,356dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM276,474$4,091,815dollars as filed
IONIS PHARMACEUTICALS INC COM462222100Stock98,267$3,882,529dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM344,922$3,500,958dollars as filed
SOLENO THERAPEUTICS INC834203309COM33,691$2,822,632dollars as filed
SAVARA INC805111101COM1,115,379$2,543,064dollars as filed
89BIO INC282559103COM212,377$2,085,542dollars as filed
CYTOKINETICS INC23282W605COM NEW61,103$2,018,843dollars as filed
BICARA THERAPEUTICS INC055477103COM189,699$1,762,304dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK1,060,764$1,612,361dollars as filed
TECTONIC THERAPEUTIC INC878972108COMMON STOCK79,058$1,570,882dollars as filed
INSMED INC COM PAR $.01457669307Stock14,571$1,466,425dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock4,874$1,400,544dollars as filed
AVIDITY BIOSCIENCES INC COM05370A108Stock47,037$1,335,851dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK87,912$1,204,394dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK360,000$1,090,800dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock111,605$1,081,452dollars as filed
LIQUIDIA CORPORATION COM NEW53635D202Stock71,071$885,545dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock17,623$831,806dollars as filed
OCULAR THERAPEUTIX INC67576A100COM88,980$825,734dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM214,412$525,309dollars as filed
WAVE LIFE SCIENCES LTD SHSY95308105Stock70,242$456,573dollars as filed
BIOMEA FUSION INC09077A106CMN250,000$450,000dollars as filed
KYVERNA THERAPEUTICS INC501976104COMMON STOCK142,542$437,604dollars as filed
CENTURY THERAPEUTICS INC15673T100COM462,963$258,657dollars as filed
SO YOUNG INTERNATIONAL INC83356Q108SPONSORED ADS72,936$226,102dollars as filed
RAPT THERAPEUTICS INC75382E208COM NEW26,034$208,272dollars as filed
LAKESHORE BIOPHARMA CO LTDG9845F208COM30,792$31,408dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001931118-25-000006this filing2025-08-14acceptance time not in the bulk data set